{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:16:34Z","timestamp":1740179794826,"version":"3.37.3"},"reference-count":7,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ EBM"],"accepted":{"date-parts":[[2019,3,22]]},"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1136\/bmjebm-2019-111184","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T13:15:10Z","timestamp":1554902110000},"page":"141-142","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["EBM verdict: should albendazole be used for treating lymphatic filariasis? No"],"prefix":"10.1136","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2420-0811","authenticated-orcid":false,"given":"Igho J","family":"Onakpoya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,4,10]]},"reference":[{"key":"2024101904300818000_24.4.141.1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1529-8019.2009.01271.x","article-title":"Filariasis: diagnosis and treatment","volume":"22","author":"Mendoza","year":"2009","journal-title":"Dermatol Ther"},{"key":"2024101904300818000_24.4.141.2","unstructured":"World Health Organization. Lymphatic filariasis.\u00a0Epidemiology. 2019. https:\/\/www.who.int\/lymphatic_filariasis\/epidemiology\/en\/."},{"key":"2024101904300818000_24.4.141.3","unstructured":"World Health Organization. Lymphatic filariasis.\u00a0Forms of Lymphatic Filariasis and diagnosis. 2019. https:\/\/www.who.int\/lymphatic_filariasis\/epidemiology\/epidemiology_forms\/en\/."},{"key":"2024101904300818000_24.4.141.4","unstructured":"World Health Organization. Lymphatic filariasis.\u00a0Global Programme to Eliminate Lymphatic Filariasis. 2019 https:\/\/www.who.int\/lymphatic_filariasis\/elimination-programme\/en\/."},{"issue":"Suppl 1","key":"2024101904300818000_24.4.141.5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1179\/000349809X12502035776595","article-title":"The development of albendazole for lymphatic filariasis","volume":"103 Suppl 1","author":"Horton","year":"2009","journal-title":"Ann Trop Med Parasitol"},{"key":"2024101904300818000_24.4.141.6","first-page":"CD003753","article-title":"Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis","volume":"1","author":"Macfarlane","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2024101904300818000_24.4.141.7","unstructured":"World Health Organization. Guideline \u2012 Alternative mass drug administration regimens to eliminate lymphatic filariasis. 2019. Accessed https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/259381\/9789241550161-eng.pdf;jsessionid=CB1B77FA2FC769DB806148E55BE54F0D?sequence=1."}],"container-title":["BMJ Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjebm-2019-111184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T11:31:08Z","timestamp":1729337468000},"score":1,"resource":{"primary":{"URL":"https:\/\/ebm.bmj.com\/lookup\/doi\/10.1136\/bmjebm-2019-111184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,10]]},"references-count":7,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,7,25]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1136\/bmjebm-2019-111184"],"URL":"https:\/\/doi.org\/10.1136\/bmjebm-2019-111184","relation":{},"ISSN":["2515-446X","2515-4478"],"issn-type":[{"type":"print","value":"2515-446X"},{"type":"electronic","value":"2515-4478"}],"subject":[],"published":{"date-parts":[[2019,4,10]]}}}